Integrating Lifestyle Factors In A Quantitative Systems Pharmacology (Qsp) Model Of Human Metabolism To Predict Long Term Cardiovascular Disease Risk

被引:0
|
作者
Venkatapurapu, Sai Phanindra [1 ]
Matthew, Chezev [1 ]
Aggarwal, Abhinav [1 ]
Dwivedi, Gaurav [1 ]
机构
[1] PwC, New York, NY USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
T-096
引用
收藏
页码:S88 / S89
页数:2
相关论文
共 50 条
  • [1] Determining the structure of a quantitative systems pharmacology (QSP) model for azathioprine metabolism
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S46 - S47
  • [2] A neuro-dynamic quantitative systems pharmacology (QSP) model for Alzheimer's disease incorporating amyloid and Tau pathophysiology
    Cao, Y.
    Willis, B.
    van Rensburg, M.
    Davies, N.
    Sachdev, P.
    Penner, N.
    Wildsmith, K.
    Charil, A.
    Horie, K.
    Koyama, A.
    Reyderman, L.
    AUSTRALASIAN JOURNAL ON AGEING, 2024, 43 : 25 - 25
  • [3] Cardiovascular risk factors predict long-term cognitive impairment after stroke
    Pascoe, C.
    Ski, C.
    Thompson, D.
    Linden, T.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2017, 16 : S43 - S44
  • [4] Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid
    Lin, Lin
    Hua, Fei
    Salinas, Cristian
    Young, Carissa
    Bussiere, Thierry
    Apgar, Joshua F.
    Burke, John M.
    Muralidharan, Kumar Kandadi
    Rajagovindan, Rajasimhan
    Nestorov, Ivan
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (03): : 362 - 372
  • [5] A Quantitative Systems Pharmacology Model to Predict the Effects of Warfarin, Rivaroxaban and Enoxaparin on the Human Coagulation Network
    Hartmann, Sonja
    Biliouris, Konstantinos
    Lesko, Lawrence J.
    Nowak-Goettl, Ulrike
    Trame, Mirjam N.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S39 - S39
  • [6] Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network
    Hartmann, S.
    Biliouris, K.
    Lesko, L. J.
    Nowak-Goettl, U.
    Trame, M. N.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (10): : 554 - 564
  • [7] Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease
    Goyer, Lysanne
    Dufour, Robert
    Janelle, Caroline
    Blais, Chantal
    L'Abbe, Christine
    Raymond, Emilie
    de Champlain, Jacques
    Larochelle, Pierre
    JOURNAL OF BEHAVIORAL MEDICINE, 2013, 36 (02) : 212 - 224
  • [8] Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease
    Lysanne Goyer
    Robert Dufour
    Caroline Janelle
    Chantal Blais
    Christine L’Abbé
    Émilie Raymond
    Jacques de Champlain
    Pierre Larochelle
    Journal of Behavioral Medicine, 2013, 36 : 212 - 224
  • [9] Long-term influence of cardiovascular risk factors in the development of thromboembolic disease
    Roca, B.
    Bahamonde, D.
    Peris, M.
    CIRCULATION, 2008, 118 (12) : E294 - E294
  • [10] The relation between ''long-term exposure'' to lifestyle during youth and young adulthood and risk factors for cardiovascular disease at adult age
    Twisk, JWR
    VanMechelen, W
    Kemper, HCG
    Post, GB
    JOURNAL OF ADOLESCENT HEALTH, 1997, 20 (04) : 309 - 319